Chemring Group reported a 5% increase in revenue to £234.3 million for the first half of 2025, driven by a 20.4% surge in its Countermeasures & Energetics division, offsetting a decline in Sensors & Information revenue due to delayed UK Strategic Defence Review; the company maintained its full-year guidance and increased its interim dividend by 4% amid a record £1.3 billion order book, with CEO Michael Ord citing continued positive momentum and robust demand.
Chemring Group reported a resilient first-half 2025, with group revenue rising 5% to £234.3 million and underlying operating profit up 8% to £27.1 million, leading to a maintained full-year outlook. This growth was predominantly fueled by a 20.4% revenue increase in its Countermeasures & Energetics division, which successfully offset a 12% revenue contraction in the Sensors & Information arm, where revenues fell to £92.6 million and order intake dropped to £70 million from £96 million. The company attributed the sensor division's slowdown to delays in the UK Strategic Defence Review, which impacted new order placements for its Roke electronic warfare subsidiary, although no programmes are reported lost. Despite this specific challenge, Chemring achieved a record £1.3 billion order book and a 42% surge in overall H1 order intake to £488 million, with 85% of anticipated FY25 revenue already secured, reflecting what management describes as a "robust demand and trading environment." Shareholder returns were enhanced through a 4% interim dividend increase to 2.7p per share and the deployment of £3.3 million under its ongoing £40 million share buyback programme.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment